Putative folding pathway of insulin-like growth factor-1

被引:32
|
作者
Rosenfeld, RD
Miller, JA
Narhi, LO
Hawkins, N
Katta, V
Lauren, S
Weiss, MA
Arakawa, T
机构
[1] Amgen Inc., Amgen Center, Thousand Oaks
[2] Amgen Inc., Amgen Center, 14-2-A-223, Thousand Oaks
关键词
D O I
10.1006/abbi.1997.9996
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Insulin-like growth factor-1 (IGF-I) has three disulfide bonds and refolding of the fully reduced molecule generates varying ratios of correctly (PII) and incorrectly (PI) folded forms via several intermediates, All of the intermediates have the disulfide bond between Cys18 and 61 formed, indicating that formation of this disulfide is the first step in refolding. In order to further understand the refolding pathway, two intermediate forms, PIII with the additional disulfide Cys(6/47) formed and PIIIa with Cys(6/48) formed, were isolated, The oxidation of the remaining Cys48 and 52 in PIII and Cys47 and 52 in PIIIa would lead to PI and PII, respectively; however, air oxidation of these resulted in a rapid reshuffling into other intermediates as well as folding into the fully oxidized forms, and this occurred whether refolding was started with PIII or PIIIa. When oxidation occurred in the presence of an excess of oxidized glutathione, the predominant species generated were various glutathione adducts regardless of the initial intermediate form, indicating that formation of the last disulfide bond is not a favorable process relative to disulfide exchange when excess disulfides from oxidized glutathione are present. Interestingly, if 80 mu M copper sulfate, an oxidant, is added to the refolding buffer, PIII resulted in formation of the PI form alone, whereas PIIIa resulted in the PII form alone. It was concluded from these results that the intermediate forms of IGF-1 can rapidly reshuffle between different disulfide structures, and that formation of the last disulfide bond is not as favorable a process as the conversion to other intermediates, The oxidation to form the last disulfide bond in PIII or PIIIa is accelerated and hence the interconversion to other intermediates is kinetically minimized only in the presence of copper sulfate. It appears, therefore, that the two intermediate forms, PIII and PIIIa, are the precursors of the corresponding fully oxidized forms, but their conversions are not energetically a favorable process. (C) 1997 Academic Press.
引用
收藏
页码:298 / 305
页数:8
相关论文
共 50 条
  • [1] Insulin-like growth factor-1
    Colbert, LH
    Rosen, CJ
    Goodpaster, BH
    Newman, AB
    Kritchevsky, SB
    Satterfield, S
    Kanaya, AM
    Taaffe, DR
    Harris, TB
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (11) : 1962 - 1963
  • [2] Insulin/Insulin-Like Growth Factor-1 Pathway in Barrett's Carcinogenesis
    Greer, K. B.
    Kresak, A.
    Bednarchik, B.
    Dawson, D.
    Li, L.
    Chak, A.
    Willis, J.
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2013, 4
  • [3] Insulin, Insulin-like Growth Factor-1 and Neurodegeneration
    Cifarelli, Vincenza
    Hays, Drew
    Hursting, Stephen D.
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2011, 9 (03) : 422 - 424
  • [4] The sequence determinant causing different folding behaviors of insulin and insulin-like growth factor-1
    Huang, Qi-Long
    Zhao, Jie
    Tang, Yue-Hua
    Shao, Su-Qing
    Xu, Gen-Jun
    Feng, You-Min
    BIOCHEMISTRY, 2007, 46 (01) : 218 - 224
  • [5] Insulin-Like Growth Factor-1 and Neuroinflammation
    Labandeira-Garcia, Jose L.
    Costa-Besada, Maria A.
    Labandeira, Carmen M.
    Villar-Cheda, Begona
    Rodriguez-Perez, Ana I.
    FRONTIERS IN AGING NEUROSCIENCE, 2017, 9
  • [6] Growth Hormone and Insulin-Like Growth Factor-1
    Nicholls, Adam R.
    Holt, Richard I. G.
    SPORTS ENDOCRINOLOGY, 2016, 47 : 101 - 114
  • [7] Doxorubicin Impairs the Insulin-Like Growth Factor-1 System and Causes Insulin-Like Growth Factor-1 Resistance in Cardiomyocytes
    Fabbi, Patrizia
    Spallarossa, Paolo
    Garibaldi, Silvano
    Barisione, Chiara
    Mura, Marzia
    Altieri, Paola
    Rebesco, Barbara
    Monti, Maria Gaia
    Canepa, Marco
    Ghigliotti, Giorgio
    Brunelli, Claudio
    Ameri, Pietro
    PLOS ONE, 2015, 10 (05):
  • [8] Insulin-like growth factor-1 pathway activation in Barrett's esophagus
    Olowe, K.
    Dawson, D.
    Willis, J.
    Miller, L.
    Taylor, J.
    Kimble, Jennifer
    Chak, Amitabh
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S140 - S141
  • [9] Serum levels of insulin-like growth factor-1 and insulin-like growth factor-1 binding proteins after radical prostatectomy
    Bubley, GJ
    Balk, SP
    Regan, MM
    Duggan, S
    Morrissey, ME
    Dewolf, WC
    Salgami, E
    Mantzoros, C
    JOURNAL OF UROLOGY, 2002, 168 (05): : 2249 - 2252
  • [10] Insulin-like growth factor-1 as a vascular protective factor
    Conti, E
    Carrozza, C
    Capoluongo, E
    Volpe, M
    Crea, F
    Zuppi, C
    Andreotti, F
    CIRCULATION, 2004, 110 (15) : 2260 - 2265